IRVING, Texas / Jun 11, 2025 / Business Wire / McKesson Corporation (NYSE: MCK) announced it will host an Investor Day on Tuesday, September 23, 2025, in New York City. The event will feature presentations by McKesson’s leadership team followed by a Q&A session with chief executive officer Brian Tyler and chief financial officer Britt Vitalone. Management will provide an update on the company’s strategic priorities, growth strategies, and business outlook.
A live webcast of the event and replay, along with the company’s slide presentation will be available on McKesson’s Investor Relations website at investor.mckesson.com, where you can find a complete listing of upcoming events, including details and updates.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories.
| Last Trade: | US$673.05 |
| Daily Change: | -0.77 -0.11 |
| Daily Volume: | 595,103 |
| Market Cap: | US$83.710B |
August 06, 2025 February 05, 2025 February 04, 2025 November 06, 2024 | |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
